Recent News

• 08.28.2025 - Trevi Therapeutics to Participate in Upcoming September Conferences
• 08.07.2025 - Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 07.31.2025 - Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025
• 07.29.2025 - Trevi Therapeutics to Participate in Upcoming August Conferences
• 07.01.2025 - Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

Recent Filings

• 08.27.2025 - 144 Report of proposed sale of securities
• 08.20.2025 - 8-K Current report
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.07.2025 - 8-K Current report
• 08.07.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.09.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 06.17.2025 - 8-K Current report